A neonate with idiopathic hyperaldosteronism
A boy with functional abnormalities of the gastro-intestinal tract, hyponatraemia, hypokalaemia and hypertension is described. All symptoms developed within the first 2 months of life. Increased aldosterone levels were associated with suppressed values in the renin-angiotensin system. The diagnosis...
Gespeichert in:
Veröffentlicht in: | Pediatric nephrology (Berlin, West) West), 1991-11, Vol.5 (6), p.680-684 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 684 |
---|---|
container_issue | 6 |
container_start_page | 680 |
container_title | Pediatric nephrology (Berlin, West) |
container_volume | 5 |
creator | VEENHOVEN, R. H VANDE WALLE, J. G DONCKERWOLCKE, R. A WIT, J. M GRIFFIVEN, A. W DERKX, F. H SCHALEKAMP, M. A |
description | A boy with functional abnormalities of the gastro-intestinal tract, hyponatraemia, hypokalaemia and hypertension is described. All symptoms developed within the first 2 months of life. Increased aldosterone levels were associated with suppressed values in the renin-angiotensin system. The diagnosis of idiopathic hyperaldosteronism was made because of adrenal hyperplasia and the failure to suppress aldosterone to undetectable levels with glucocorticoids. Treatment with spironolactone alone, or in combination with either intravenous dopamine or ibopamine orally, amiloride, enalapril, hydralazine or clonidine corrected serum potassium values but failed to normalize blood pressure and to correct plasma renin activity and plasma aldosterone. However, the combination of spironolactone with nifedipine decreased blood pressure. Abnormal gastro-intestinal motility was corrected by low doses of oral magnesium hydroxide. To assess intracellular calcium homeostasis, the patient's peripheral blood mononuclear cells were incubated with increasing concentrations of calcium. As these cells failed to maintain physiological calcium concentration, a defect in intracellular calcium homeostasis was suspected. |
doi_str_mv | 10.1007/BF00857870 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72600130</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72600130</sourcerecordid><originalsourceid>FETCH-LOGICAL-c270t-efafa01adf14afe0cf40365b7e907d165d50732db0ef3950137524aa46c82d1e3</originalsourceid><addsrcrecordid>eNpFkDtLA0EUhQdRYow29sIWYiGu3nnt7JYxGBUCNgrplpt5kJF9ObNB8u_dkGCqW5zvHC4fIdcUHimAenqeA-RS5QpOyJgKzlJa5MtTMoaC0xQEXZ6Tixi_YYfl2YiMqMqGghqTh2nS2LbB3ia_vl8n3vi2w37tdbLedjZgZdrY29A2PtaX5MxhFe3V4U7I1_zlc_aWLj5e32fTRaqZgj61Dh0CReOoQGdBOwE8kytlC1CGZtJIUJyZFVjHCwmUK8kEosh0zgy1fELu9rtdaH82NvZl7aO2VYXDr5tYKpbB0IIBvN-DOrQxBuvKLvgaw7akUO7UlEc1A3xzWN2samuO6N7FkN8ecowaKxew0T7-YxKYKJTgfyd6ago</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72600130</pqid></control><display><type>article</type><title>A neonate with idiopathic hyperaldosteronism</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>VEENHOVEN, R. H ; VANDE WALLE, J. G ; DONCKERWOLCKE, R. A ; WIT, J. M ; GRIFFIVEN, A. W ; DERKX, F. H ; SCHALEKAMP, M. A</creator><creatorcontrib>VEENHOVEN, R. H ; VANDE WALLE, J. G ; DONCKERWOLCKE, R. A ; WIT, J. M ; GRIFFIVEN, A. W ; DERKX, F. H ; SCHALEKAMP, M. A</creatorcontrib><description>A boy with functional abnormalities of the gastro-intestinal tract, hyponatraemia, hypokalaemia and hypertension is described. All symptoms developed within the first 2 months of life. Increased aldosterone levels were associated with suppressed values in the renin-angiotensin system. The diagnosis of idiopathic hyperaldosteronism was made because of adrenal hyperplasia and the failure to suppress aldosterone to undetectable levels with glucocorticoids. Treatment with spironolactone alone, or in combination with either intravenous dopamine or ibopamine orally, amiloride, enalapril, hydralazine or clonidine corrected serum potassium values but failed to normalize blood pressure and to correct plasma renin activity and plasma aldosterone. However, the combination of spironolactone with nifedipine decreased blood pressure. Abnormal gastro-intestinal motility was corrected by low doses of oral magnesium hydroxide. To assess intracellular calcium homeostasis, the patient's peripheral blood mononuclear cells were incubated with increasing concentrations of calcium. As these cells failed to maintain physiological calcium concentration, a defect in intracellular calcium homeostasis was suspected.</description><identifier>ISSN: 0931-041X</identifier><identifier>EISSN: 1432-198X</identifier><identifier>DOI: 10.1007/BF00857870</identifier><identifier>PMID: 1768577</identifier><identifier>CODEN: PENED3</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Aldosterone - blood ; Aldosterone - urine ; Biological and medical sciences ; Calcium - metabolism ; Gastrointestinal Diseases - metabolism ; Hormones. Endocrine system ; Humans ; Hyperaldosteronism - drug therapy ; Hyperaldosteronism - metabolism ; Hypokalemia - drug therapy ; Hypokalemia - metabolism ; Infant, Newborn ; Magnesium Hydroxide - therapeutic use ; Male ; Medical sciences ; Nifedipine - therapeutic use ; Pharmacology. Drug treatments ; Renin-Angiotensin System - physiology ; Spironolactone - therapeutic use</subject><ispartof>Pediatric nephrology (Berlin, West), 1991-11, Vol.5 (6), p.680-684</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c270t-efafa01adf14afe0cf40365b7e907d165d50732db0ef3950137524aa46c82d1e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5024974$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1768577$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VEENHOVEN, R. H</creatorcontrib><creatorcontrib>VANDE WALLE, J. G</creatorcontrib><creatorcontrib>DONCKERWOLCKE, R. A</creatorcontrib><creatorcontrib>WIT, J. M</creatorcontrib><creatorcontrib>GRIFFIVEN, A. W</creatorcontrib><creatorcontrib>DERKX, F. H</creatorcontrib><creatorcontrib>SCHALEKAMP, M. A</creatorcontrib><title>A neonate with idiopathic hyperaldosteronism</title><title>Pediatric nephrology (Berlin, West)</title><addtitle>Pediatr Nephrol</addtitle><description>A boy with functional abnormalities of the gastro-intestinal tract, hyponatraemia, hypokalaemia and hypertension is described. All symptoms developed within the first 2 months of life. Increased aldosterone levels were associated with suppressed values in the renin-angiotensin system. The diagnosis of idiopathic hyperaldosteronism was made because of adrenal hyperplasia and the failure to suppress aldosterone to undetectable levels with glucocorticoids. Treatment with spironolactone alone, or in combination with either intravenous dopamine or ibopamine orally, amiloride, enalapril, hydralazine or clonidine corrected serum potassium values but failed to normalize blood pressure and to correct plasma renin activity and plasma aldosterone. However, the combination of spironolactone with nifedipine decreased blood pressure. Abnormal gastro-intestinal motility was corrected by low doses of oral magnesium hydroxide. To assess intracellular calcium homeostasis, the patient's peripheral blood mononuclear cells were incubated with increasing concentrations of calcium. As these cells failed to maintain physiological calcium concentration, a defect in intracellular calcium homeostasis was suspected.</description><subject>Aldosterone - blood</subject><subject>Aldosterone - urine</subject><subject>Biological and medical sciences</subject><subject>Calcium - metabolism</subject><subject>Gastrointestinal Diseases - metabolism</subject><subject>Hormones. Endocrine system</subject><subject>Humans</subject><subject>Hyperaldosteronism - drug therapy</subject><subject>Hyperaldosteronism - metabolism</subject><subject>Hypokalemia - drug therapy</subject><subject>Hypokalemia - metabolism</subject><subject>Infant, Newborn</subject><subject>Magnesium Hydroxide - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nifedipine - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Renin-Angiotensin System - physiology</subject><subject>Spironolactone - therapeutic use</subject><issn>0931-041X</issn><issn>1432-198X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkDtLA0EUhQdRYow29sIWYiGu3nnt7JYxGBUCNgrplpt5kJF9ObNB8u_dkGCqW5zvHC4fIdcUHimAenqeA-RS5QpOyJgKzlJa5MtTMoaC0xQEXZ6Tixi_YYfl2YiMqMqGghqTh2nS2LbB3ia_vl8n3vi2w37tdbLedjZgZdrY29A2PtaX5MxhFe3V4U7I1_zlc_aWLj5e32fTRaqZgj61Dh0CReOoQGdBOwE8kytlC1CGZtJIUJyZFVjHCwmUK8kEosh0zgy1fELu9rtdaH82NvZl7aO2VYXDr5tYKpbB0IIBvN-DOrQxBuvKLvgaw7akUO7UlEc1A3xzWN2samuO6N7FkN8ecowaKxew0T7-YxKYKJTgfyd6ago</recordid><startdate>199111</startdate><enddate>199111</enddate><creator>VEENHOVEN, R. H</creator><creator>VANDE WALLE, J. G</creator><creator>DONCKERWOLCKE, R. A</creator><creator>WIT, J. M</creator><creator>GRIFFIVEN, A. W</creator><creator>DERKX, F. H</creator><creator>SCHALEKAMP, M. A</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199111</creationdate><title>A neonate with idiopathic hyperaldosteronism</title><author>VEENHOVEN, R. H ; VANDE WALLE, J. G ; DONCKERWOLCKE, R. A ; WIT, J. M ; GRIFFIVEN, A. W ; DERKX, F. H ; SCHALEKAMP, M. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c270t-efafa01adf14afe0cf40365b7e907d165d50732db0ef3950137524aa46c82d1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Aldosterone - blood</topic><topic>Aldosterone - urine</topic><topic>Biological and medical sciences</topic><topic>Calcium - metabolism</topic><topic>Gastrointestinal Diseases - metabolism</topic><topic>Hormones. Endocrine system</topic><topic>Humans</topic><topic>Hyperaldosteronism - drug therapy</topic><topic>Hyperaldosteronism - metabolism</topic><topic>Hypokalemia - drug therapy</topic><topic>Hypokalemia - metabolism</topic><topic>Infant, Newborn</topic><topic>Magnesium Hydroxide - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nifedipine - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Renin-Angiotensin System - physiology</topic><topic>Spironolactone - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VEENHOVEN, R. H</creatorcontrib><creatorcontrib>VANDE WALLE, J. G</creatorcontrib><creatorcontrib>DONCKERWOLCKE, R. A</creatorcontrib><creatorcontrib>WIT, J. M</creatorcontrib><creatorcontrib>GRIFFIVEN, A. W</creatorcontrib><creatorcontrib>DERKX, F. H</creatorcontrib><creatorcontrib>SCHALEKAMP, M. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric nephrology (Berlin, West)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VEENHOVEN, R. H</au><au>VANDE WALLE, J. G</au><au>DONCKERWOLCKE, R. A</au><au>WIT, J. M</au><au>GRIFFIVEN, A. W</au><au>DERKX, F. H</au><au>SCHALEKAMP, M. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A neonate with idiopathic hyperaldosteronism</atitle><jtitle>Pediatric nephrology (Berlin, West)</jtitle><addtitle>Pediatr Nephrol</addtitle><date>1991-11</date><risdate>1991</risdate><volume>5</volume><issue>6</issue><spage>680</spage><epage>684</epage><pages>680-684</pages><issn>0931-041X</issn><eissn>1432-198X</eissn><coden>PENED3</coden><abstract>A boy with functional abnormalities of the gastro-intestinal tract, hyponatraemia, hypokalaemia and hypertension is described. All symptoms developed within the first 2 months of life. Increased aldosterone levels were associated with suppressed values in the renin-angiotensin system. The diagnosis of idiopathic hyperaldosteronism was made because of adrenal hyperplasia and the failure to suppress aldosterone to undetectable levels with glucocorticoids. Treatment with spironolactone alone, or in combination with either intravenous dopamine or ibopamine orally, amiloride, enalapril, hydralazine or clonidine corrected serum potassium values but failed to normalize blood pressure and to correct plasma renin activity and plasma aldosterone. However, the combination of spironolactone with nifedipine decreased blood pressure. Abnormal gastro-intestinal motility was corrected by low doses of oral magnesium hydroxide. To assess intracellular calcium homeostasis, the patient's peripheral blood mononuclear cells were incubated with increasing concentrations of calcium. As these cells failed to maintain physiological calcium concentration, a defect in intracellular calcium homeostasis was suspected.</abstract><cop>Heidelberg</cop><pub>Springer</pub><pmid>1768577</pmid><doi>10.1007/BF00857870</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0931-041X |
ispartof | Pediatric nephrology (Berlin, West), 1991-11, Vol.5 (6), p.680-684 |
issn | 0931-041X 1432-198X |
language | eng |
recordid | cdi_proquest_miscellaneous_72600130 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Aldosterone - blood Aldosterone - urine Biological and medical sciences Calcium - metabolism Gastrointestinal Diseases - metabolism Hormones. Endocrine system Humans Hyperaldosteronism - drug therapy Hyperaldosteronism - metabolism Hypokalemia - drug therapy Hypokalemia - metabolism Infant, Newborn Magnesium Hydroxide - therapeutic use Male Medical sciences Nifedipine - therapeutic use Pharmacology. Drug treatments Renin-Angiotensin System - physiology Spironolactone - therapeutic use |
title | A neonate with idiopathic hyperaldosteronism |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T06%3A02%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20neonate%20with%20idiopathic%20hyperaldosteronism&rft.jtitle=Pediatric%20nephrology%20(Berlin,%20West)&rft.au=VEENHOVEN,%20R.%20H&rft.date=1991-11&rft.volume=5&rft.issue=6&rft.spage=680&rft.epage=684&rft.pages=680-684&rft.issn=0931-041X&rft.eissn=1432-198X&rft.coden=PENED3&rft_id=info:doi/10.1007/BF00857870&rft_dat=%3Cproquest_cross%3E72600130%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72600130&rft_id=info:pmid/1768577&rfr_iscdi=true |